SCHEMBL4167207

SCHEMBL4167207

COc1ccc(NCCCOc2ccc(Cc3c(C(C)C)cn4ccccc34)cc2)cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.40
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
HPGD P15428 1/20 0.35
MAPT P10636 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.35
ALOX12 P18054 1/20 0.35
ABCB1 P08183 2/20 0.34
GAA P10253 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
CACNA1B Q00975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8239232 0.82 NPSR1 (0.42) PPARGALDH1A1KDM4EMEN1KMT2A
Hydrochloric Acid SCHEMBL9598758 0.81 NPSR1 (0.41) PPARGALDH1A1KDM4EMEN1KMT2A
SCHEMBL4167552 0.81 CYP3A4 (0.49) KDM4EMEN1KMT2AMAPTLMNA
SCHEMBL4182006 0.80 ITGB3 (0.40) ALDH1A1KDM4EMEN1KMT2AL3MBTL1
SCHEMBL4179216 0.74 HRH3 (0.53) HRH3
SCHEMBL4174422 0.73 PPARG (0.36) PPARGALDH1A1KDM4EMEN1KMT2A
SCHEMBL4173331 0.73 HRH3 (0.62) MEN1KMT2AHRH3
SCHEMBL4177653 0.72 HRH3 (0.52) HRH3
SCHEMBL9603542 0.72 HTR6 (0.47) ALDH1A1KDM4EMEN1KMT2ANPSR1
SCHEMBL6451740 0.72 MAPT (0.44) PPARGALDH1A1KDM4ENPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090017112-A1 Compounds for Inhibiting Beta-Amyloid Production ROSKAMP RESEARCH LLC (US) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090017112-A1 Compounds for Inhibiting Beta-Amyloid Production PSEN1, PSEN2, APP PPARG 1742/4885ALDH1A1 2818/4885KDM4E 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.